Back to BlackRock, Inc. BlackRock, Inc.

ACRSACRS
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ACLARIS THERAPEUTICS INC

BlackRock, Inc. holds 10M shares of ACRS (ACLARIS THERAPEUTICS INC), worth $53.1M as of 2026-Q2. The position was increased (+35.5% shares). ACRS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$53.1M

Current Shares

10M

Total Value Change

+$51.1M

Total Shares Change

+8.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
10M
+35.5%
$53.1M0.0%$5.29
38
2026-Q1
Increased
7.4M
+8.8%
$27.8M0.0%$3.75
31
2025-Q4
Increased
6.8M
+19.6%
$20.5M0.0%$3.01
34
2025-Q3
Increased
5.7M
+3.2%
$10.8M0.0%$1.90
29
2025-Q2
Increased
5.5M
+305.2%
$7.8M0.0%$1.42
44
2025-Q1
Increased
1.4M
+8.2%
$2.1M0.0%$1.53
19
2024-Q4
Decreased
1.3M
-26.5%
$3.1M0.0%$2.48
0
2024-Q3
First report
1.7M
-
$2M0.0%$1.15
0

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used